Industry Research Reports

Home > Reports > Pharma & Healthcare > BCG Tuberculosis (TB) Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

BCG Tuberculosis (TB) Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published: 2024-01-24

Pages: 93 Pages

Report ld: 2340849

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

BCG Tuberculosis (TB) Vaccine is a vaccine primarily used against tuberculosis.

The global market for BCG Tuberculosis (TB) Vaccine was estimated to be worth US$ 30 million in 2023 and is forecast to a readjusted size of US$ 36 million by 2030 with a CAGR of 2.9% during the forecast period 2024-2030

BCG Tuberculosis (TB) Vaccine Market Size

M= millions and B=billions

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for BCG Tuberculosis (TB) Vaccine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of BCG Tuberculosis (TB) Vaccine by region & country, by Type, and by Application.

The BCG Tuberculosis (TB) Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding BCG Tuberculosis (TB) Vaccine.

Market Segmentation

Report Metric
Details
Report Title
BCG Tuberculosis (TB) Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Forecasted Market Size in 2030
US$ 36 million
CAGR(2024-2030)
2.9%
Market Size Available for Years
2019-2030
Global BCG Tuberculosis (TB) Vaccine Companies Covered
Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, Serum Institute of India, Intervax, GSBPL
Global BCG Tuberculosis (TB) Vaccine Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global BCG Tuberculosis (TB) Vaccine Market, Segment by Type
Immune BCG

Therapy BCG
Global BCG Tuberculosis (TB) Vaccine Market, Segment by Application
Hospital

Clinic
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of BCG Tuberculosis (TB) Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of BCG Tuberculosis (TB) Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of BCG Tuberculosis (TB) Vaccine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 BCG Tuberculosis (TB) Vaccine Product Introduction
    1.2 Global BCG Tuberculosis (TB) Vaccine Market Size Forecast
        1.2.1 Global BCG Tuberculosis (TB) Vaccine Sales Value (2019-2030)
        1.2.2 Global BCG Tuberculosis (TB) Vaccine Sales Volume (2019-2030)
        1.2.3 Global BCG Tuberculosis (TB) Vaccine Sales Price (2019-2030)
    1.3 BCG Tuberculosis (TB) Vaccine Market Trends & Drivers
        1.3.1 BCG Tuberculosis (TB) Vaccine Industry Trends
        1.3.2 BCG Tuberculosis (TB) Vaccine Market Drivers & Opportunity
        1.3.3 BCG Tuberculosis (TB) Vaccine Market Challenges
        1.3.4 BCG Tuberculosis (TB) Vaccine Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global BCG Tuberculosis (TB) Vaccine Players Revenue Ranking (2023)
    2.2 Global BCG Tuberculosis (TB) Vaccine Revenue by Company (2019-2024)
    2.3 Global BCG Tuberculosis (TB) Vaccine Players Sales Volume Ranking (2023)
    2.4 Global BCG Tuberculosis (TB) Vaccine Sales Volume by Company Players (2019-2024)
    2.5 Global BCG Tuberculosis (TB) Vaccine Average Price by Company (2019-2024)
    2.6 Key Manufacturers BCG Tuberculosis (TB) Vaccine Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers BCG Tuberculosis (TB) Vaccine Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of BCG Tuberculosis (TB) Vaccine
    2.9 BCG Tuberculosis (TB) Vaccine Market Competitive Analysis
        2.9.1 BCG Tuberculosis (TB) Vaccine Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by BCG Tuberculosis (TB) Vaccine Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in BCG Tuberculosis (TB) Vaccine as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Immune BCG
        3.1.2 Therapy BCG
    3.2 Global BCG Tuberculosis (TB) Vaccine Sales Value by Type
        3.2.1 Global BCG Tuberculosis (TB) Vaccine Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global BCG Tuberculosis (TB) Vaccine Sales Value, by Type (2019-2030)
        3.2.3 Global BCG Tuberculosis (TB) Vaccine Sales Value, by Type (%) (2019-2030)
    3.3 Global BCG Tuberculosis (TB) Vaccine Sales Volume by Type
        3.3.1 Global BCG Tuberculosis (TB) Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global BCG Tuberculosis (TB) Vaccine Sales Volume, by Type (2019-2030)
        3.3.3 Global BCG Tuberculosis (TB) Vaccine Sales Volume, by Type (%) (2019-2030)
    3.4 Global BCG Tuberculosis (TB) Vaccine Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hospital
        4.1.2 Clinic
    4.2 Global BCG Tuberculosis (TB) Vaccine Sales Value by Application
        4.2.1 Global BCG Tuberculosis (TB) Vaccine Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global BCG Tuberculosis (TB) Vaccine Sales Value, by Application (2019-2030)
        4.2.3 Global BCG Tuberculosis (TB) Vaccine Sales Value, by Application (%) (2019-2030)
    4.3 Global BCG Tuberculosis (TB) Vaccine Sales Volume by Application
        4.3.1 Global BCG Tuberculosis (TB) Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global BCG Tuberculosis (TB) Vaccine Sales Volume, by Application (2019-2030)
        4.3.3 Global BCG Tuberculosis (TB) Vaccine Sales Volume, by Application (%) (2019-2030)
    4.4 Global BCG Tuberculosis (TB) Vaccine Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global BCG Tuberculosis (TB) Vaccine Sales Value by Region
        5.1.1 Global BCG Tuberculosis (TB) Vaccine Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global BCG Tuberculosis (TB) Vaccine Sales Value by Region (2019-2024)
        5.1.3 Global BCG Tuberculosis (TB) Vaccine Sales Value by Region (2025-2030)
        5.1.4 Global BCG Tuberculosis (TB) Vaccine Sales Value by Region (%), (2019-2030)
    5.2 Global BCG Tuberculosis (TB) Vaccine Sales Volume by Region
        5.2.1 Global BCG Tuberculosis (TB) Vaccine Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global BCG Tuberculosis (TB) Vaccine Sales Volume by Region (2019-2024)
        5.2.3 Global BCG Tuberculosis (TB) Vaccine Sales Volume by Region (2025-2030)
        5.2.4 Global BCG Tuberculosis (TB) Vaccine Sales Volume by Region (%), (2019-2030)
    5.3 Global BCG Tuberculosis (TB) Vaccine Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America BCG Tuberculosis (TB) Vaccine Sales Value, 2019-2030
        5.4.2 North America BCG Tuberculosis (TB) Vaccine Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe BCG Tuberculosis (TB) Vaccine Sales Value, 2019-2030
        5.5.2 Europe BCG Tuberculosis (TB) Vaccine Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific BCG Tuberculosis (TB) Vaccine Sales Value, 2019-2030
        5.6.2 Asia Pacific BCG Tuberculosis (TB) Vaccine Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America BCG Tuberculosis (TB) Vaccine Sales Value, 2019-2030
        5.7.2 South America BCG Tuberculosis (TB) Vaccine Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa BCG Tuberculosis (TB) Vaccine Sales Value, 2019-2030
        5.8.2 Middle East & Africa BCG Tuberculosis (TB) Vaccine Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions BCG Tuberculosis (TB) Vaccine Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions BCG Tuberculosis (TB) Vaccine Sales Value
        6.2.1 Key Countries/Regions BCG Tuberculosis (TB) Vaccine Sales Value, 2019-2030
        6.2.2 Key Countries/Regions BCG Tuberculosis (TB) Vaccine Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States BCG Tuberculosis (TB) Vaccine Sales Value, 2019-2030
        6.3.2 United States BCG Tuberculosis (TB) Vaccine Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States BCG Tuberculosis (TB) Vaccine Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe BCG Tuberculosis (TB) Vaccine Sales Value, 2019-2030
        6.4.2 Europe BCG Tuberculosis (TB) Vaccine Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe BCG Tuberculosis (TB) Vaccine Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China BCG Tuberculosis (TB) Vaccine Sales Value, 2019-2030
        6.5.2 China BCG Tuberculosis (TB) Vaccine Sales Value by Type (%), 2023 VS 2030
        6.5.3 China BCG Tuberculosis (TB) Vaccine Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan BCG Tuberculosis (TB) Vaccine Sales Value, 2019-2030
        6.6.2 Japan BCG Tuberculosis (TB) Vaccine Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan BCG Tuberculosis (TB) Vaccine Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea BCG Tuberculosis (TB) Vaccine Sales Value, 2019-2030
        6.7.2 South Korea BCG Tuberculosis (TB) Vaccine Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea BCG Tuberculosis (TB) Vaccine Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia BCG Tuberculosis (TB) Vaccine Sales Value, 2019-2030
        6.8.2 Southeast Asia BCG Tuberculosis (TB) Vaccine Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia BCG Tuberculosis (TB) Vaccine Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India BCG Tuberculosis (TB) Vaccine Sales Value, 2019-2030
        6.9.2 India BCG Tuberculosis (TB) Vaccine Sales Value by Type (%), 2023 VS 2030
        6.9.3 India BCG Tuberculosis (TB) Vaccine Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Merck
        7.1.1 Merck Company Information
        7.1.2 Merck Introduction and Business Overview
        7.1.3 Merck BCG Tuberculosis (TB) Vaccine Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 Merck BCG Tuberculosis (TB) Vaccine Product Offerings
        7.1.5 Merck Recent Development
    7.2 Sanofi Pasteur
        7.2.1 Sanofi Pasteur Company Information
        7.2.2 Sanofi Pasteur Introduction and Business Overview
        7.2.3 Sanofi Pasteur BCG Tuberculosis (TB) Vaccine Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 Sanofi Pasteur BCG Tuberculosis (TB) Vaccine Product Offerings
        7.2.5 Sanofi Pasteur Recent Development
    7.3 Japan BCG Lab
        7.3.1 Japan BCG Lab Company Information
        7.3.2 Japan BCG Lab Introduction and Business Overview
        7.3.3 Japan BCG Lab BCG Tuberculosis (TB) Vaccine Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 Japan BCG Lab BCG Tuberculosis (TB) Vaccine Product Offerings
        7.3.5 Japan BCG Lab Recent Development
    7.4 China National Biotec
        7.4.1 China National Biotec Company Information
        7.4.2 China National Biotec Introduction and Business Overview
        7.4.3 China National Biotec BCG Tuberculosis (TB) Vaccine Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 China National Biotec BCG Tuberculosis (TB) Vaccine Product Offerings
        7.4.5 China National Biotec Recent Development
    7.5 Serum Institute of India
        7.5.1 Serum Institute of India Company Information
        7.5.2 Serum Institute of India Introduction and Business Overview
        7.5.3 Serum Institute of India BCG Tuberculosis (TB) Vaccine Sales, Revenue and Gross Margin (2019-2024)
        7.5.4 Serum Institute of India BCG Tuberculosis (TB) Vaccine Product Offerings
        7.5.5 Serum Institute of India Recent Development
    7.6 Intervax
        7.6.1 Intervax Company Information
        7.6.2 Intervax Introduction and Business Overview
        7.6.3 Intervax BCG Tuberculosis (TB) Vaccine Sales, Revenue and Gross Margin (2019-2024)
        7.6.4 Intervax BCG Tuberculosis (TB) Vaccine Product Offerings
        7.6.5 Intervax Recent Development
    7.7 GSBPL
        7.7.1 GSBPL Company Information
        7.7.2 GSBPL Introduction and Business Overview
        7.7.3 GSBPL BCG Tuberculosis (TB) Vaccine Sales, Revenue and Gross Margin (2019-2024)
        7.7.4 GSBPL BCG Tuberculosis (TB) Vaccine Product Offerings
        7.7.5 GSBPL Recent Development

 8 Industry Chain Analysis
    8.1 BCG Tuberculosis (TB) Vaccine Industrial Chain
    8.2 BCG Tuberculosis (TB) Vaccine Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 BCG Tuberculosis (TB) Vaccine Sales Model
        8.5.2 Sales Channel
        8.5.3 BCG Tuberculosis (TB) Vaccine Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. BCG Tuberculosis (TB) Vaccine Market Trends
    Table 2. BCG Tuberculosis (TB) Vaccine Market Drivers & Opportunity
    Table 3. BCG Tuberculosis (TB) Vaccine Market Challenges
    Table 4. BCG Tuberculosis (TB) Vaccine Market Restraints
    Table 5. Global BCG Tuberculosis (TB) Vaccine Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global BCG Tuberculosis (TB) Vaccine Revenue Market Share by Company (2019-2024)
    Table 7. Global BCG Tuberculosis (TB) Vaccine Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global BCG Tuberculosis (TB) Vaccine Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market BCG Tuberculosis (TB) Vaccine Price by Company (2019-2024) & (USD/Unit)
    Table 10. Key Manufacturers BCG Tuberculosis (TB) Vaccine Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers BCG Tuberculosis (TB) Vaccine Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of BCG Tuberculosis (TB) Vaccine
    Table 13. Global BCG Tuberculosis (TB) Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in BCG Tuberculosis (TB) Vaccine as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global BCG Tuberculosis (TB) Vaccine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global BCG Tuberculosis (TB) Vaccine Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global BCG Tuberculosis (TB) Vaccine Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global BCG Tuberculosis (TB) Vaccine Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global BCG Tuberculosis (TB) Vaccine Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global BCG Tuberculosis (TB) Vaccine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global BCG Tuberculosis (TB) Vaccine Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global BCG Tuberculosis (TB) Vaccine Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global BCG Tuberculosis (TB) Vaccine Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global BCG Tuberculosis (TB) Vaccine Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global BCG Tuberculosis (TB) Vaccine Price by Type (2019-2024) & (USD/Unit)
    Table 27. Global BCG Tuberculosis (TB) Vaccine Price by Type (2025-2030) & (USD/Unit)
    Table 28. Global BCG Tuberculosis (TB) Vaccine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global BCG Tuberculosis (TB) Vaccine Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global BCG Tuberculosis (TB) Vaccine Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global BCG Tuberculosis (TB) Vaccine Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global BCG Tuberculosis (TB) Vaccine Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global BCG Tuberculosis (TB) Vaccine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global BCG Tuberculosis (TB) Vaccine Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global BCG Tuberculosis (TB) Vaccine Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global BCG Tuberculosis (TB) Vaccine Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global BCG Tuberculosis (TB) Vaccine Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global BCG Tuberculosis (TB) Vaccine Price by Application (2019-2024) & (USD/Unit)
    Table 39. Global BCG Tuberculosis (TB) Vaccine Price by Application (2025-2030) & (USD/Unit)
    Table 40. Global BCG Tuberculosis (TB) Vaccine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global BCG Tuberculosis (TB) Vaccine Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global BCG Tuberculosis (TB) Vaccine Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global BCG Tuberculosis (TB) Vaccine Sales Value by Region (2019-2024) & (%)
    Table 44. Global BCG Tuberculosis (TB) Vaccine Sales Value by Region (2025-2030) & (%)
    Table 45. Global BCG Tuberculosis (TB) Vaccine Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global BCG Tuberculosis (TB) Vaccine Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global BCG Tuberculosis (TB) Vaccine Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global BCG Tuberculosis (TB) Vaccine Sales Volume by Region (2019-2024) & (%)
    Table 49. Global BCG Tuberculosis (TB) Vaccine Sales Volume by Region (2025-2030) & (%)
    Table 50. Global BCG Tuberculosis (TB) Vaccine Average Price by Region (2019-2024) & (USD/Unit)
    Table 51. Global BCG Tuberculosis (TB) Vaccine Average Price by Region (2025-2030) & (USD/Unit)
    Table 52. Key Countries/Regions BCG Tuberculosis (TB) Vaccine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions BCG Tuberculosis (TB) Vaccine Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions BCG Tuberculosis (TB) Vaccine Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions BCG Tuberculosis (TB) Vaccine Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions BCG Tuberculosis (TB) Vaccine Sales Volume, (2025-2030) & (K Units)
    Table 57. Merck Company Information
    Table 58. Merck Introduction and Business Overview
    Table 59. Merck BCG Tuberculosis (TB) Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 60. Merck BCG Tuberculosis (TB) Vaccine Product Offerings
    Table 61. Merck Recent Development
    Table 62. Sanofi Pasteur Company Information
    Table 63. Sanofi Pasteur Introduction and Business Overview
    Table 64. Sanofi Pasteur BCG Tuberculosis (TB) Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 65. Sanofi Pasteur BCG Tuberculosis (TB) Vaccine Product Offerings
    Table 66. Sanofi Pasteur Recent Development
    Table 67. Japan BCG Lab Company Information
    Table 68. Japan BCG Lab Introduction and Business Overview
    Table 69. Japan BCG Lab BCG Tuberculosis (TB) Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 70. Japan BCG Lab BCG Tuberculosis (TB) Vaccine Product Offerings
    Table 71. Japan BCG Lab Recent Development
    Table 72. China National Biotec Company Information
    Table 73. China National Biotec Introduction and Business Overview
    Table 74. China National Biotec BCG Tuberculosis (TB) Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 75. China National Biotec BCG Tuberculosis (TB) Vaccine Product Offerings
    Table 76. China National Biotec Recent Development
    Table 77. Serum Institute of India Company Information
    Table 78. Serum Institute of India Introduction and Business Overview
    Table 79. Serum Institute of India BCG Tuberculosis (TB) Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 80. Serum Institute of India BCG Tuberculosis (TB) Vaccine Product Offerings
    Table 81. Serum Institute of India Recent Development
    Table 82. Intervax Company Information
    Table 83. Intervax Introduction and Business Overview
    Table 84. Intervax BCG Tuberculosis (TB) Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 85. Intervax BCG Tuberculosis (TB) Vaccine Product Offerings
    Table 86. Intervax Recent Development
    Table 87. GSBPL Company Information
    Table 88. GSBPL Introduction and Business Overview
    Table 89. GSBPL BCG Tuberculosis (TB) Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 90. GSBPL BCG Tuberculosis (TB) Vaccine Product Offerings
    Table 91. GSBPL Recent Development
    Table 92. Key Raw Materials Lists
    Table 93. Raw Materials Key Suppliers Lists
    Table 94. BCG Tuberculosis (TB) Vaccine Downstream Customers
    Table 95. BCG Tuberculosis (TB) Vaccine Distributors List
    Table 96. Research Programs/Design for This Report
    Table 97. Key Data Information from Secondary Sources
    Table 98. Key Data Information from Primary Sources
List of Figures
    Figure 1. BCG Tuberculosis (TB) Vaccine Product Picture
    Figure 2. Global BCG Tuberculosis (TB) Vaccine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global BCG Tuberculosis (TB) Vaccine Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global BCG Tuberculosis (TB) Vaccine Sales Volume (2019-2030) & (K Units)
    Figure 5. Global BCG Tuberculosis (TB) Vaccine Sales Price (2019-2030) & (USD/Unit)
    Figure 6. BCG Tuberculosis (TB) Vaccine Report Years Considered
    Figure 7. Global BCG Tuberculosis (TB) Vaccine Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global BCG Tuberculosis (TB) Vaccine Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by BCG Tuberculosis (TB) Vaccine Revenue in 2023
    Figure 10. BCG Tuberculosis (TB) Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Immune BCG Picture
    Figure 12. Therapy BCG Picture
    Figure 13. Global BCG Tuberculosis (TB) Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global BCG Tuberculosis (TB) Vaccine Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global BCG Tuberculosis (TB) Vaccine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 16. Global BCG Tuberculosis (TB) Vaccine Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global BCG Tuberculosis (TB) Vaccine Price by Type (2019-2030) & (USD/Unit)
    Figure 18. Product Picture of Hospital
    Figure 19. Product Picture of Clinic
    Figure 20. Global BCG Tuberculosis (TB) Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 21. Global BCG Tuberculosis (TB) Vaccine Sales Value Market Share by Application, 2023 & 2030
    Figure 22. Global BCG Tuberculosis (TB) Vaccine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 23. Global BCG Tuberculosis (TB) Vaccine Sales Volume Market Share by Application, 2023 & 2030
    Figure 24. Global BCG Tuberculosis (TB) Vaccine Price by Application (2019-2030) & (USD/Unit)
    Figure 25. North America BCG Tuberculosis (TB) Vaccine Sales Value (2019-2030) & (US$ Million)
    Figure 26. North America BCG Tuberculosis (TB) Vaccine Sales Value by Country (%), 2023 VS 2030
    Figure 27. Europe BCG Tuberculosis (TB) Vaccine Sales Value (2019-2030) & (US$ Million)
    Figure 28. Europe BCG Tuberculosis (TB) Vaccine Sales Value by Country (%), 2023 VS 2030
    Figure 29. Asia Pacific BCG Tuberculosis (TB) Vaccine Sales Value (2019-2030) & (US$ Million)
    Figure 30. Asia Pacific BCG Tuberculosis (TB) Vaccine Sales Value by Country (%), 2023 VS 2030
    Figure 31. South America BCG Tuberculosis (TB) Vaccine Sales Value (2019-2030) & (US$ Million)
    Figure 32. South America BCG Tuberculosis (TB) Vaccine Sales Value by Country (%), 2023 VS 2030
    Figure 33. Middle East & Africa BCG Tuberculosis (TB) Vaccine Sales Value (2019-2030) & (US$ Million)
    Figure 34. Middle East & Africa BCG Tuberculosis (TB) Vaccine Sales Value by Country (%), 2023 VS 2030
    Figure 35. Key Countries/Regions BCG Tuberculosis (TB) Vaccine Sales Value (%), (2019-2030)
    Figure 36. Key Countries/Regions BCG Tuberculosis (TB) Vaccine Sales Volume (%), (2019-2030)
    Figure 37. United States BCG Tuberculosis (TB) Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 38. United States BCG Tuberculosis (TB) Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 39. United States BCG Tuberculosis (TB) Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 40. Europe BCG Tuberculosis (TB) Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Europe BCG Tuberculosis (TB) Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 42. Europe BCG Tuberculosis (TB) Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 43. China BCG Tuberculosis (TB) Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 44. China BCG Tuberculosis (TB) Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 45. China BCG Tuberculosis (TB) Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 46. Japan BCG Tuberculosis (TB) Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Japan BCG Tuberculosis (TB) Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 48. Japan BCG Tuberculosis (TB) Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 49. South Korea BCG Tuberculosis (TB) Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 50. South Korea BCG Tuberculosis (TB) Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 51. South Korea BCG Tuberculosis (TB) Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 52. Southeast Asia BCG Tuberculosis (TB) Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 53. Southeast Asia BCG Tuberculosis (TB) Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 54. Southeast Asia BCG Tuberculosis (TB) Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 55. India BCG Tuberculosis (TB) Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 56. India BCG Tuberculosis (TB) Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 57. India BCG Tuberculosis (TB) Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 58. BCG Tuberculosis (TB) Vaccine Industrial Chain
    Figure 59. BCG Tuberculosis (TB) Vaccine Manufacturing Cost Structure
    Figure 60. Channels of Distribution (Direct Sales, and Distribution)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed

Description

BCG Tuberculosis (TB) Vaccine is a vaccine primarily used against tuberculosis.

The global market for BCG Tuberculosis (TB) Vaccine was estimated to be worth US$ 30 million in 2023 and is forecast to a readjusted size of US$ 36 million by 2030 with a CAGR of 2.9% during the forecast period 2024-2030

Market Segmentation